LIGAND PHARMACEUTICALS INCORPORATED: capex
| Value | {"amount": 4458000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-12-31 |
| Status | current |
| Entity | LIGAND PHARMACEUTICALS INCORPORATED |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:53:36.541691+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/179c027d-6c91-47eb-8f3f-dfcbbf56d2a4
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000886163-21-000050Retrieved: 2026-08-19T08:53:36.541691+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000886163/capex/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/179c027d-6c91-47eb-8f3f-dfcbbf56d2a4
History
- no predecessors — first report